Cargando…
Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations
OBJECTIVES: Corruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors globally. Throughout the COVID-19 pandemic, weakened...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772658/ https://www.ncbi.nlm.nih.gov/pubmed/36549737 http://dx.doi.org/10.1136/bmjopen-2022-064137 |
_version_ | 1784855028451770368 |
---|---|
author | Gorodensky, Ariel Bowra, Andrea Saeed, Gul Kohler, Jillian |
author_facet | Gorodensky, Ariel Bowra, Andrea Saeed, Gul Kohler, Jillian |
author_sort | Gorodensky, Ariel |
collection | PubMed |
description | OBJECTIVES: Corruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors globally. Throughout the COVID-19 pandemic, weakened health systems and overlooked regulatory processes have increased corruption risks. The objective of this study is thus to explore the strengths and weaknesses of these organisations’ anti-corruption mechanisms and their trajectories since the pandemic began. DESIGN, SETTING AND PARTICIPANTS: 25 semistructured key informant interviews with a total of 27 participants were conducted via Zoom between April and July 2021 with informants from WHO, World Bank, Global Fund and UNDP, other non-governmental organisations involved in anti-corruption and academic institutions. Key informant selection was guided by purposive and snowball sampling. Detailed interview notes were qualitatively coded by three researchers. Data analysis followed an inductive-deductive hybrid thematic analysis framework. RESULTS: The findings demonstrate that WHO, World Bank, Global Fund and UNDP have shifted from criminalisation/punitive approaches to anti-corruption to preventative ones and that anti-corruption initiatives are strong when they are well funded, explicitly address corruption and are complemented by strong monitoring and evaluation mechanisms. Weaknesses in the organisations’ approaches to anti-corruption include one-size-fits-all approaches, lack of political will to address corruption and zero-tolerance policies for corruption. The COVID-19 pandemic has highlighted the necessity of improving anti-corruption by promoting strong accountability and transparency in health systems. CONCLUSIONS: Results from this study highlight the strengths, weaknesses and recent trajectories of anti-corruption in the Global Fund, World Bank, UNDP and WHO. This study underscores the importance of implementing strong and robust anti-corruption mechanisms specifically geared towards corruption prevention that remain resilient even in times of emergency. |
format | Online Article Text |
id | pubmed-9772658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-97726582022-12-23 Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations Gorodensky, Ariel Bowra, Andrea Saeed, Gul Kohler, Jillian BMJ Open Global Health OBJECTIVES: Corruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors globally. Throughout the COVID-19 pandemic, weakened health systems and overlooked regulatory processes have increased corruption risks. The objective of this study is thus to explore the strengths and weaknesses of these organisations’ anti-corruption mechanisms and their trajectories since the pandemic began. DESIGN, SETTING AND PARTICIPANTS: 25 semistructured key informant interviews with a total of 27 participants were conducted via Zoom between April and July 2021 with informants from WHO, World Bank, Global Fund and UNDP, other non-governmental organisations involved in anti-corruption and academic institutions. Key informant selection was guided by purposive and snowball sampling. Detailed interview notes were qualitatively coded by three researchers. Data analysis followed an inductive-deductive hybrid thematic analysis framework. RESULTS: The findings demonstrate that WHO, World Bank, Global Fund and UNDP have shifted from criminalisation/punitive approaches to anti-corruption to preventative ones and that anti-corruption initiatives are strong when they are well funded, explicitly address corruption and are complemented by strong monitoring and evaluation mechanisms. Weaknesses in the organisations’ approaches to anti-corruption include one-size-fits-all approaches, lack of political will to address corruption and zero-tolerance policies for corruption. The COVID-19 pandemic has highlighted the necessity of improving anti-corruption by promoting strong accountability and transparency in health systems. CONCLUSIONS: Results from this study highlight the strengths, weaknesses and recent trajectories of anti-corruption in the Global Fund, World Bank, UNDP and WHO. This study underscores the importance of implementing strong and robust anti-corruption mechanisms specifically geared towards corruption prevention that remain resilient even in times of emergency. BMJ Publishing Group 2022-12-21 /pmc/articles/PMC9772658/ /pubmed/36549737 http://dx.doi.org/10.1136/bmjopen-2022-064137 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Global Health Gorodensky, Ariel Bowra, Andrea Saeed, Gul Kohler, Jillian Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
title | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
title_full | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
title_fullStr | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
title_full_unstemmed | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
title_short | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
title_sort | anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
topic | Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772658/ https://www.ncbi.nlm.nih.gov/pubmed/36549737 http://dx.doi.org/10.1136/bmjopen-2022-064137 |
work_keys_str_mv | AT gorodenskyariel anticorruptioninglobalhealthsystemsusingkeyinformantinterviewstoexploreanticorruptionaccountabilityandtransparencyininternationalhealthorganisations AT bowraandrea anticorruptioninglobalhealthsystemsusingkeyinformantinterviewstoexploreanticorruptionaccountabilityandtransparencyininternationalhealthorganisations AT saeedgul anticorruptioninglobalhealthsystemsusingkeyinformantinterviewstoexploreanticorruptionaccountabilityandtransparencyininternationalhealthorganisations AT kohlerjillian anticorruptioninglobalhealthsystemsusingkeyinformantinterviewstoexploreanticorruptionaccountabilityandtransparencyininternationalhealthorganisations |